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1

Abstract

2

A 13-year-old castrated male Maine coon cat with a 5-year history of atypical

3

mycobacteriosis was euthanized and submitted for necropsy. The cat had been kept in

4

clinical remission since diagnosis using a combination of the antimycobacterial drug

5

clofazimine and additional multimodal antimicrobial therapy. Grossly, tissues were

6

diffusely discolored red-brown to yellow. Histologically, the myocardial interstitum was

7

expanded by numerous, often multinucleated cells, which were distended by uniformly

8

shaped acicular cytoplasmic spaces. These cells were immunopositive for CD18 and

9

immunonegative for desmin, suggesting a histiocytic rather than muscular origin.

10

Macrophages in other tissues contained similar acicular spaces. Ultrastructurally, the

11

spaces were surrounded by two lipid membranes, resembling an autophagosome.

12

Based upon the clinical history and histologic, immunohistochemical, and ultrastructural

13

data, we diagnosed clofazimine crystal storage. To our knowledge, this is the first report

14

of clofazimine storage in a cat or within myocardial interstitial macrophages.

15

Keywords: clofazimine, feline, heart, histiocyte, mycobacteria, Mycobacterium avium

16

complex, mycobacteriosis

17
18
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1

Clofazimine is a highly lipophilic phenazine dye with antimycobacterial and anti-

2

inflammatory properties. This drug is listed as an essential medicine by the World

3

Health Organization and is most commonly utilized in humans for the treatment of

4

leprosy and multi-drug resistant tuberculosis.27 In humans, adverse effects are generally

5

self-limiting and include ichthyosis and pink discoloration of the skin in approximately

6

94% of patients,20 less frequently, gastrointestinal pain20 and discoloration of the

7

sclera,3 and rarely clofazimine storage enteropathy.24,26 Histologically, clofazimine

8

storage enteropathy in humans is characterized by expansion of the gastrointestinal

9

lamina propria by crystal-laden macrophages following prolonged treatment with high

10

doses of clofazimine.24,26 This condition can lead to unnecessary laparotomy, either due

11

to clinical signs suggestive of gastrointestinal obstruction24 or due to its radiologic

12

similarity to neoplastic processes.25 In humans, storage of clofazimine crystals has also

13

been reported in the macrophages of many tissues, including the lung,14,21,23 lymphoid

14

organs, 19 liver,9 and eye.11

15

In veterinary medicine, clofazimine is utilized in dogs and cats for the treatment

16

of mycobacteriosis.4,16,22 Adverse effects are rarely reported but include hepatotoxicity,

17

gastrointestinal signs, photosensitization, discoloration of the skin, and pitting corneal

18

lesions.4,16 Histologically confirmed cases of clofazimine storage enteropathy associated

19

with treatment for mycobacteriosis have not been reported in domestic animals.

20

However, mice fed approximately 10mg/kg/day of clofazimine developed pink

21

discoloration of the skin and hair and storage of clofazimine crystals within

22

macrophages in the intestine, liver, spleen, and lungs.2 Interestingly for the current

23

report, in this murine model, clofazimine did not accumulate within the heart.2 With
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1

transmission electron microscopy, intrahistiocytic clofazimine crystals have been shown

2

to be enveloped in a double lipid membrane, similar to those surrounding

3

autophagosomes.1

4

A 13-year-old castrated male Maine coon cat was submitted for necropsy. Eight

5

years prior to necropsy, the cat developed self-limiting lymphadenomegaly, followed by

6

immune-mediated retinal detachment, anemia, and thrombocytopenia. He was treated

7

with multiple immunosuppressive medications over the next three years, culminating in

8

hepatotoxicity due to cyclosporine overdosage 4.5 years prior to necropsy. Thereafter,

9

immunosuppression was gradually tapered and discontinued, and the cat developed

10

marked lymphadenomegaly and chemosis. Pyogranulomatous lymphadenitis with

11

intracytoplasmic negative-staining bacilli was identified following cytologic evaluation of

12

an enlarged superficial cervical lymph node. Mycobacterium avium was detected by

13

mycobacterial culture and PCRperformed on 4 excised enlarged retropharyngeal lymph

14

nodes. It was not possible to determine whether the cat’s mycobacteriosis reflected

15

opportunistic infection secondary to chronic immunosuppression or if it had been the

16

trigger for the cat’s original presentation with immune-mediated retinal detachment,

17

anemia, and thrombocytopenia.

18

A detailed description of the clinical course of this case and the treatments are

19

presented in the Supplemental Materials. In short, for 8 years, the cat had been treated

20

with various antimycobacterial agents and adjustments had been made as necessary to

21

maintain clinical remission. These medications included enrofloxacin (32.5mg, q24h),

22

rifampin (75mg, q24h), clarithromycin (62.5mg, q12h), amikacin (100mg, q24h),

23

ethambutol (300mg, q12h), moxifloxacin (30mg, q24h), minocycline (50mg, q24h),
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1

azithromycin (50mg, q24h), pradofloxacin (25mg, q24h), and clofazimine (50mg, q24h).

2

Clofazimine therapy was initiated 4 years prior to necropsy but was discontinued 5

3

months prior to euthanasia due to unavailability for use in veterinary medicine in the

4

United States. Three months following initiation of treatment with clofazimine, the cat’s

5

skin, fur, and sclera developed a pink hue; this discoloration waned after discontinuation

6

of the medication. The cat was presented for euthanasia due to two weeks of weakness

7

and rapidly progressive weight loss. At the time of death, the cat was being treated with

8

azithromycin, pradofloxacin, and minocycline.

9

Gross findings at necropsy included purple-brown to red discoloration of most

10

tissues, including skeletal muscle, kidney, liver, and bone marrow; adipose tissue was

11

discolored yellow to brown. Tissues stained cutting surfaces bright pink, discolored

12

fixation solutions red-orange, and stained histological processing equipment bright pink

13

to dark red. The heart was subjectively enlarged with thickened ventricular walls and

14

weighed 33.8g, which was 0.78% of body weight (University of Tennessee internal

15

reference range 0.3-0.45%) and the liver weighed 240g, which was 5.5% of body weight

16

(University of Tennessee internal reference range 3-3.5%). Cavitary effusions were not

17

present. With the exception of the discoloration and multiple chronic renal infarcts, all

18

organs were grossly unremarkable.

19

Samples of all major tissues were collected and fixed in 10% buffered neutral

20

formalin, processed routinely, and routinely stained with hematoxylin and eosin for light

21

microscopic examination. For desmin immunohistochemistry Biocare’s Decloaker and

22

Reveal Buffer (Biocare, Pacheco, CA) was used for antigen retrieval, and sections were

23

treated with monoclonal mouse anti- desmin antibodies (Dako, Santa Clara, CA,
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catalogue #M0760; 1:100 dilution, 30 minutes) For CD18 immunohistochemistry

2

Carezyme I: Trypsin Kit (Biocare, Pacheco, CA) was used for antigen retrieval, then

3

endogenous peroxidase activity was blocked with 3% H2O2 and monoclonal mouse anti-

4

feline CD18 antibody was applied (clone Fe3.9f2, Peter Moore, University of California-

5

Davis, Davis, CA; 1:10 dilution, 30 minutes,).6,8 Diaminobenzidine tetrahydrochloride

6

was utilized as chromogen with hematoxylin counterstain. .

7

For transmission electron microscopy, formalin-fixed samples of myocardium

8

were washed in 0.1M sodium phosphate buffer, post-fixed in buffered 2% osmium

9

tetroxide for 60 minutes, washed in water, and dehydrated in a graded ethanol series

10

with final dehydration in propylene oxide. Samples then were embedded in Embed 812

11

and semi-thin (1000nm) and thin sections (100nm) were prepared on a Leica EM UC7

12

ultra-microtome and stained with UranyLess stain (Electron Microscopy Sciences,

13

Hatfield, PA) followed by Reynolds lead citrate to increase the contrast. Sections were

14

imaged in a Zeiss Libra 200MC operating at 200kV.

15

The most striking histologic feature was expansion of approximately 80% of the

16

myocardial interstitium by many cells with up to 20 nuclei and abundant pale

17

eosinophilic cytoplasm distended by regularly shaped clear acicular spaces (Figures 1

18

and 2). Similar cells, often multinucleated, were also identified within the interstitium of

19

the skeletal muscle, although in lower numbers. These cells were immunoreactive for

20

CD18 (Figure 3) and did not label with desmin, indicating a leukocytic origin. Given their

21

multinucleation and similarity to Kupffer cells and pulmonary alveolar macropahges,

22

they were interpreted as histiocytes. Additionally, myocardiocytes were variably sized

23

(up to three-fold variation) and contained perinuclear brown pigment granules
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1

(lipofuscin). Kupffer cells, (Figure 4) and pulmonary alveolar macrophages also

2

contained similar clear, acicular spaces. Kupffer cells also contained abundant brown

3

granular pigment, which stained blue with Prussian blue (data not shown) and was

4

interpreted as hemosiderin. Notably, there was no evidence of these acicular spaces

5

within macrophages in the intestinal lamina propria.

6

Ultrastructurally, the spaces in myocardial macrophages were polygonal,

7

electron-lucent, and lined by lipid membranes (Figures 5 and 6), consistent with an

8

autophagosome. Other histologic findings included regionally extensive acute hepatic

9

necrosis and chronic tubulointerstitial nephritis with chronic infarcts. Staining of multiple

10

tissues with Ziehl-Neelsen and Fite-Faraco acid fast stains did not demonstrate acid-

11

fast bacteria. Although considered a significant contributor to clinical decline, a definitive

12

cause of the hepatic necrosis was not identified.

13

Given the historical treatment with clofazimine and the histologic and

14

ultrastructural appearance of the crystalline spaces in macrophages, a diagnosis of

15

clofazimine storage was made. Clofazimine crystals are soluble in organic solvents and

16

alcohols and are therefore lost during routine tissue processing for histology and

17

ultrastructural study, leaving only clear acicular spaces.25 In order to see crystals

18

histologically, frozen sections must be examined. Frozen samples were not collected in

19

this case.

20

To our knowledge, this is the first report of clofazimine accumulation within the

21

heart of a cat. Cardiotoxicity resulting in arrhythmias has previously been reported in

22

humans treated with clofazimine for prolonged periods 7,10 and cardiac accumulation of

23

clofazimine has been demonstrated in humans18 and rats.17 However, those studies did
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1

not include histologic evaluation for comparison to this case. In mice and humans with

2

many forms of chronic heart disease, the number of macrophages within the myocardial

3

interstitium increases.12 Cats with hypertrophic cardiomyopathy have recently been

4

shown to have increased numbers of macrophages within the myocardial interstitium.15

5

Although lacking the classical finding of myocardial disarray, the variably-sized

6

myocardiocytes in this cat, the subjective cardiomegaly with ventricular thickening, and

7

increased cardiac weight (0.78% of body weight) are suggestive of, though not

8

diagnostic for, hypertrophic cardiomyopathy. Alternatively, the increased heart weight

9

may have been the result of infiltration of the myocardium by clofazimine-laden

10

macrophages. A similar phenomenon of myocardial histiocytosis has also been

11

demonstrated in humans and mice with chronic kidney disease5 but not, to our

12

knowledge, in cats. The accumulation of clofazimine crystals within Kupffer cells2 and

13

pulmonary alveolar macrophages14,21,23 has been previously documented in

14

experimental and human literature and closely mirrors this case. Interestingly in this

15

case, and in contrast to humans24,26 and experimental models2, macrophages in the

16

intestinal lamina propria did not contain clofazimine crystals. The accumulation of

17

crystal-laden macrophages within the skeletal muscle intersititum, to the authors’

18

knowledge has not been previously reported and may suggest an unusual distribution of

19

clofazimine crystal storage in cats.

20

Although clofazimine is a mainstay of treatment of mycobacteriosis in cats,16,22

21

adverse effects rarely have been reported. Previously reported adverse effects are

22

limited to gastrointestinal upset and photosensitization, both of which typically resolve

23

following cessation of the medication. This report demonstrates clofazimine crystal
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1

storage within myocardial and skeletal muscle interstitial macrophages, Kupffer cells,

2

and pulmonary alveolar macrophages. Myocardial accumulation of clofazimine in this

3

case could represent an adverse effect of clofazimine, or could potentially a be

4

consequence of underlying cardiac pathological changes. In this case, the multiple

5

adverse effects associated with administration of other medications may reflect an

6

individual or species-specific sensitivity to various medications. Unfortunately, the role

7

of clofazimine in the clinical decline in this case is not determined.

8
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Figure Legend
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Figures 1-4. Clofazimine storage, cat. Figure 1. Myocardium. Diffusely, the interstitium
is expanded by cells (macrophages) with abundant pale eosinophilic cytoplasm and
intracytoplasmic acicular spaces. (HE) Figure 2. Myocardium. Higher magnification of
Figure 1. The cells within the interstitium have up to 20 nuclei and their cytoplasm is
distended by abundant acicular spaces (arrows). (HE) Figure 3. Myocardium. Cells
within the interstitial spaces are immunoreactive to CD18, indicating a leukocytic origin.
Immunohistochemistry for CD18. Figure 4. Liver. Fixed macrophages including Kupffer
cells contain intracytoplasmic crystalline spaces and abundant granular golden-brown
pigment (hemosiderin). (HE)

33
34
35
36

Figures 5 and 6. Clofazimine storage, myocardium, cat Transmission electron
microscopy. Figure 5. Ultrastructurally, macrophages contain intracytoplasmic
membrane-bound acicular spaces. Figure 6. Higher magnification of Figure 5. An
acicular space (asterisk) is bound by a lipid bilayer (arrows).
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